08/09/2024 6:01 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2024 6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024 4:06 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 4:07 PM | Johnson David Michael (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:09 PM | Kariuki Enoch (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:11 PM | Skvarka Jan (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
05/31/2024 5:27 PM | Gallagher Cam (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 5:28 PM | Gallagher Cam (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2024 6:16 AM | Zentalis Pharmaceuticals (Filer)
| Form DEFA14A | |
05/29/2024 6:33 AM | Walker Luke Nathaniel (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/29/2024 6:34 AM | Walker Luke Nathaniel (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 6:46 PM | HAUSMAN DIANA (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 6:47 PM | HAUSMAN DIANA (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024 6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 6:05 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 3:34 PM | Zentalis Pharmaceuticals (Filer)
| Form DEF 14A | |
04/29/2024 3:36 PM | Zentalis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/11/2024 6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 6:02 AM | Vultaggio Vincent (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/09/2024 3:30 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 4:14 PM | Zentalis Pharmaceuticals (Filer)
| Form S-3ASR | |
02/29/2024 4:20 PM | Zentalis Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024 6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/27/2024 6:08 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 3:57 PM | CITADEL ADVISORS LLC (Filed by) Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024 6:43 PM | Avidity Partners Management LP (Filed by) Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024 7:21 PM | Gallagher Cam (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 7:22 PM | Epperly Melissa B, (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 7:23 PM | Gallagher Cam (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 7:25 PM | Epperly Melissa B, (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 7:25 PM | Bunker Kevin D. (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 7:40 AM | WELLINGTON MANAGEMENT GROUP LLP (Filed by) Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/05/2024 6:11 PM | Blackwell Kimberly (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:12 PM | Epperly Melissa B, (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:13 PM | Gallagher Cam (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:14 PM | Paul Andrea (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:15 PM | Lackner Mark (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 6:16 PM | HAUSMAN DIANA (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 8:26 PM | Epperly Melissa B, (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
02/02/2024 8:27 PM | Bunker Kevin D. (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 8:28 PM | Brownstein Carrie (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 8:29 PM | Paul Andrea (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 8:29 PM | Lackner Mark (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 8:26 PM | Gallagher Cam (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024 2:26 PM | BlackRock Inc. (Filed by) Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024 6:52 AM | STATE STREET CORP (Filed by) Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024 6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 7:19 PM | Lackner Mark (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/03/2024 7:21 PM | Lackner Mark (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 4:47 PM | Bunker Kevin D. (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 4:24 PM | Blackwell Kimberly (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 4:24 PM | Johnson David Michael (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 8:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 8:06 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023 2:40 PM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by) Zentalis Pharmaceuticals (Subject)
| Form SC 13G | |
10/06/2023 6:18 PM | Epperly Melissa B, (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 6:19 PM | Bunker Kevin D. (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 6:19 PM | Brownstein Carrie (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 4:00 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 7:25 PM | Epperly Melissa B, (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2023 7:26 PM | Bunker Kevin D. (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2023 7:28 PM | Brownstein Carrie (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:11 PM | Skvarka Jan (Reporting) Zentalis Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 3:09 PM | Skvarka Jan (Reporting) Zentalis Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |